Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Assets Average (2020 - 2025)

Historic Assets Average for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $1.2 billion.

  • Harmony Biosciences Holdings' Assets Average rose 2965.03% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 2965.03%. This contributed to the annual value of $905.3 million for FY2024, which is 2190.31% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Assets Average is $1.2 billion, which was up 2965.03% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Assets Average registered a high of $1.2 billion during Q3 2025, and its lowest value of $348.5 million during Q2 2021.
  • For the 5-year period, Harmony Biosciences Holdings' Assets Average averaged around $709.8 million, with its median value being $737.6 million (2023).
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 1035.78% in 2021, then skyrocketed by 5976.69% in 2022.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Assets Average stood at $412.3 million in 2021, then surged by 59.77% to $658.7 million in 2022, then increased by 20.64% to $794.6 million in 2023, then increased by 21.28% to $963.7 million in 2024, then rose by 20.18% to $1.2 billion in 2025.
  • Its Assets Average was $1.2 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.0 billion in Q1 2025.